Adam Sichol is a founder and the chief executive as of spring 2021 of Longfellow Real Estate Partners. He is also one of the five partners in the firm.
Longfellow as of early 2021 was one of the most distinguished players in the life sciences real estate sector, having bought or developed more than 9 million square feet since the firm was founded more than a decade ago.
The Boston-based life sciences investor, developer and manager sported as of spring 2021 a portfolio of more than 6 million square feet — about 4 or 5 percent of U.S. lab space — and was managing a development pipeline of about 4 million square feet in the best biotech markets in the country.
Even during the coronavirus pandemic, Sichol and his partners kept expanding, capitalizing on a demand for life sciences space fueled in part by the race for therapeutics and vaccines to combat that very pandemic. Longfellow expanded its portfolio by almost 1 million square feet in 2020, and, along the way, reorganized internally to handle that and further growth. The reorganization included making Sichol CEO.
Sichol graduated from Hamilton College and earned an MBA from Dartmouth. He started his real estate career at JLL, and helped start Longfellow in 2009 after stints elsewhere.